BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28185878)

  • 1. Chronic mild stress augments MPTP induced neurotoxicity in a murine model of Parkinson's disease.
    Janakiraman U; Manivasagam T; Justin Thenmozhi A; Dhanalakshmi C; Essa MM; Song BJ; Guillemin GJ
    Physiol Behav; 2017 May; 173():132-143. PubMed ID: 28185878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice.
    Janakiraman U; Manivasagam T; Thenmozhi AJ; Essa MM; Barathidasan R; SaravanaBabu C; Guillemin GJ; Khan MA
    PLoS One; 2016; 11(1):e0146671. PubMed ID: 26765842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice.
    Shi X; Chen YH; Liu H; Qu HD
    Mol Med Rep; 2016 Sep; 14(3):2397-404. PubMed ID: 27484986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice.
    Choi JG; Huh E; Ju IG; Kim N; Yun J; Oh MS
    J Neurol Sci; 2018 Sep; 392():77-82. PubMed ID: 30031172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway.
    Zhu G; Li J; He L; Wang X; Hong X
    Br J Pharmacol; 2015 May; 172(9):2354-68. PubMed ID: 25560396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP/probenecid mouse model of Parkinson's disease.
    Selvakumar GP; Janakiraman U; Essa MM; Justin Thenmozhi A; Manivasagam T
    Brain Res; 2014 Oct; 1585():23-36. PubMed ID: 24657313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA.
    Zhao TT; Kim KS; Shin KS; Park HJ; Kim HJ; Lee KE; Lee MK
    BMC Complement Altern Med; 2017 Sep; 17(1):449. PubMed ID: 28877690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson's disease: The Role of MAPK, PI3K-Akt-GSK3β and mTOR Signalling Pathways.
    Nataraj J; Manivasagam T; Justin Thenmozhi A; Essa MM
    Neurochem Res; 2017 May; 42(5):1354-1365. PubMed ID: 28181071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease.
    Luchtman DW; Meng Q; Song C
    Behav Brain Res; 2012 Jan; 226(2):386-96. PubMed ID: 21971013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: involvement of ERK1/2-Nrf2 signaling pathway.
    Wang XL; Xing GH; Hong B; Li XM; Zou Y; Zhang XJ; Dong MX
    Life Sci; 2014 Oct; 114(2):77-85. PubMed ID: 25132361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease.
    Martin HL; Santoro M; Mustafa S; Riedel G; Forrester JV; Teismann P
    Glia; 2016 Mar; 64(3):386-95. PubMed ID: 26511587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression regulation of Bcl2, Bax and cytochrome-C by geraniol on chronic MPTP/probenecid induced C57BL/6 mice model of Parkinson's disease.
    Rekha KR; Selvakumar GP
    Chem Biol Interact; 2014 Jun; 217():57-66. PubMed ID: 24768735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Regulatory Mechanism and Toxicology of Neurodegenerative Processes in MPTP/Probenecid-Induced Progressive Parkinson's Disease Mice Model Revealed by Transcriptome.
    Yang W; Hao W; Meng Z; Ding S; Li X; Zhang T; Huang W; Xu L; Zhang Y; Yang J; Gu X
    Mol Neurobiol; 2021 Feb; 58(2):603-616. PubMed ID: 32997292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease.
    Jarras H; Bourque M; Poirier AA; Morissette M; Coulombe K; Di Paolo T; Soulet D
    J Neuroendocrinol; 2020 Jan; 32(1):e12782. PubMed ID: 31430407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
    Anandhan A; Tamilselvam K; Radhiga T; Rao S; Essa MM; Manivasagam T
    Brain Res; 2012 Jan; 1433():104-13. PubMed ID: 22138428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.